Action EGRX EAGLE PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Eagle Pharmaceuticals, Inc.

Actions

EGRX

US2697961082

Temps réel estimé Cboe BZX
Autres places de cotation
 18:17:24 02/05/2024 		Varia. 5j. Varia. 1 janv.
4,51 USD +7,64% Graphique intraday de Eagle Pharmaceuticals, Inc. +5,90% -14,15%
11/03 Mise à jour sectorielle : Les actions du secteur de la santé sont plus faibles en fin d'après-midi MT
11/03 Mise à jour sectorielle : Soins de santé MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting
North American Morning Briefing : Investors Brace -2-
North American Morning Briefing : Stock Futures -2-
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
North American Morning Briefing : Stock Futures -2-
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
North American Morning Briefing : Inflation Data, -2-
North American Morning Briefing : Tech in Focus on -2-
North American Morning Briefing : Investors -2-
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Eagle Pharmaceuticals CFO Resigns; Shares Fall
North American Morning Briefing : Stock Futures -2-
Eagle Pharmaceuticals, Inc. Announces CFO Changes
Eagle Pharmaceuticals, Inc. Announces Board and Committee Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action EGRX
  4. Actualités Eagle Pharmaceuticals, Inc.
  5. Autres langues